A second wave of trials in the Risperdal mass tort has been scheduled for October, and several more cases are gearing up for trials in the spring.

Two trials against Janssen Pharmaceuticals, the maker of the antipsychotic Risperdal, have been set to begin in October, and according to attorneys involved in the mass tort, pretrial discovery has begun in about 10 more cases. Trials in those cases have been tentatively set to begin in the spring.

Earlier this year, two cases involving Risperdal went to trial, and a third resolved in an undisclosed settlement.